from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2121c/hisG

LFCtreatmentdescriptionclass of inhibitor

-0.330

Amikacinug/mL Amikacintranslation

0.546

Cap5-10ug/mL Capreomycintranslation

0.499

Rox10-50 ug/mL Roxithromycintranslation

0.059

SM2-5 ug/mL Streptomycintranslation

0.272

Tet5-10 ug/mL Tetracyclinetranslation

-0.219

Rif0.2-5ug/mL Rifampicintranscription

0.458

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.561

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.434

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.703

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.117

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.646

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.426

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.149

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.050

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.283

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.204

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.132

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-2.360

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.632

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.205

Nigericin50 uM Nigericinrespiration

-0.279

TRC10-150 ug/mL Triclosanrespiration

-0.246

TRZ10-25 ug/mL Thioridazinerespiration

2.302

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-2.056

menadione6-10 ug/mL Menadionerespiration

0.398

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.522

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.827

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.005

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.207

NRP_1Non-replicating persistence stage 1dosRassociated

0.246

Amp0.2mg/mL AmpicillincellWall

0.034

Cephalexin20-100 ug/mL CephalexincellWall

0.188

Cerulenin0.32-5 ug/mL CerulenincellWall

0.342

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.957

EMB10-20 ug/mL EthambutolcellWall

0.072

Eta12-40 ug/mL EthionamidecellWall

0.348

INH0.2-0.4 ug/mL IsoniazidcellWall

0.101

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.480

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.265

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.089

BZA0.12 mg/mL BenzamidearomaticAmides

0.378

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.439

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.512

H2O24 mM hydrogen peroxideDNAdamaging

0.372

Levo10 ug/mL LevofloxacinDNAdamaging

0.397

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.220

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.896

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.453

UVUV-irradiationDNAdamaging

-1.724

ARP41-4 ug/mL Antitubercular compound ARP4?

0.208

Antimycin12.5-50 ug/mL Antimycin A?

-0.366

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.650

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.238

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.004

PA8240.2-2 ug/mL PA-824?

-0.234

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.074

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.994

Verapamil50 uM Verapamil?

-0.739

mercaptoethanol2 mM 2-Mercaptoethanol?

0.226

methoxatin10-20 ug/mL Methoxatin?